Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 22, 2017BLEACHING CREAM 0.1% CREAMLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0533-2017Class IITerminatedMar 22, 2017BL 20%/4% CREAMLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0532-2017Class IITerminatedMar 22, 2017BENZOYL PEROXIDE 5% CLINDAMYCIN 1.2%Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0531-2017Class IITerminatedMar 22, 2017ADAPALENE 0.1%Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0530-2017Class IITerminatedMar 22, 2017BICARBONATE 10%Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0529-2017Class IITerminatedMar 22, 2017MINOXADIL all strength including 2%Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0528-2017Class IITerminatedMar 22, 20175-FLUOROURACIL IN VANICREAMLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0527-2017Class IITerminatedMar 22, 2017TACROLIMUS 0.1% Ointment and TACROLIMUS 0.1%/KETOCONAZOLE 2%Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0526-2017Class IITerminatedMar 22, 2017KETOCONAZOLE 2%/HYDROCORTISONE 1.5% CREAMLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0525-2017Class IITerminatedMar 22, 2017HCG and HCG with resveratrol Human Chorionic Gonadotropin in different strengths: HCG 300 UNITS/RESVERATROL...Lack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0524-2017Class IITerminatedMar 22, 2017CANTHARADIN 0.7% SOLUTION and CANTHARIDAN / PODOPHYLLUM SOLUTIONLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0523-2017Class IITerminatedMar 22, 2017Human Chorionic GonadotropinLack of Assurance of Sterility: There are also CGMP Deviations.Synergy Rx · D-0522-2017Class IIITerminatedMar 22, 2017PreviDent 5000 ppmLabel Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.Colgate Palmolive Co · D-0521-2017Class IITerminatedMar 22, 2017GlipiZIDE Extended-release tabletsFailed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.Amerisource Health Services · D-0520-2017Class IIITerminatedMar 22, 2017Clindamycin Phosphate Topical Solution USPCGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.G & W Laboratories, Inc. · D-0519-2017Class IITerminatedMar 22, 2017Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for InjectionCGMP DeviationsIsomeric Pharmacy Solution, LLC · D-0518-2017Class IITerminatedMar 22, 2017Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mgFailed Impurities/Degradation SpecificationsTeva Pharmaceuticals USA · D-0517-2017Class IIITerminatedMar 22, 2017PROTONIX I.VSubpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.Pfizer Inc. · D-0516-2017Class IITerminatedMar 15, 2017Pioglitazone and Glimepiride TabletsFailed Dissolution SpecificationsSandoz Inc · D-0515-2017Class IIITerminatedMar 15, 2017Levofloxacin Ophthalmic SolutionFailed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.Actavis Inc · D-0514-2017Class IICompletedMar 15, 2017Aspirin Chewable TabletsPresence of Foreign Substance: foreign material found in the bulk inventory.Mckesson Packaging Services · D-0513-2017Class IITerminatedMar 15, 2017Edex (alprostadil for injection) 10mcgLack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanksEndo Pharmaceuticals, Inc. · D-0512-2017Class IIITerminatedMar 15, 2017Risedronate Sodium Delayed-release TabletsFailed Dissolution Specifications: low out of specification dissolution results found during stability testing.Teva Pharmaceuticals USA · D-0511-2017Class IITerminatedMar 15, 2017Calcipotriene Cream 0.0005%Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the...Leo Pharma Inc · D-0510-2017Class IITerminatedMar 15, 2017Mirtazapine TabletsPresence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingledMylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-0493-2017Class IITerminatedMar 15, 2017Mirtazapine TabletsPresence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottleMylan Pharmaceuticals Inc. · D-0492-2017Class IIITerminatedMar 8, 2017ZenataneFailed dissolution specifications - low dissolution results at S3 stage.Dr. Reddy's Laboratories, Inc. · D-0509-2017Class IIITerminatedMar 8, 2017ZenataneFailed dissolution specifications - low dissolution results at S3 stage.Dr. Reddy's Laboratories, Inc. · D-0508-2017Class IIITerminatedMar 8, 2017ZenataneFailed dissolution specifications - low dissolution results at S3 stage.Dr. Reddy's Laboratories, Inc. · D-0507-2017Class IIITerminatedMar 8, 2017ZenataneFailed dissolution specifications - low dissolution results at S3 stage.Dr. Reddy's Laboratories, Inc. · D-0506-2017Class ITerminatedMar 8, 2017Nano PNC WaterMarketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.Pacific Medical Solutions · D-0505-2017Class IIITerminatedMar 8, 2017Salicylic Acid CreamFailed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.L. Perrigo Company · D-0504-2017Class IIITerminatedMar 8, 2017Salicylic Acid ShampooFailed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.L. Perrigo Company · D-0503-2017Class IITerminatedMar 8, 2017Alfuzosin Hydrochloride Extended-release TabletsPresence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.Sun Pharmaceutical Industries, Inc. · D-0502-2017Class IITerminatedMar 8, 2017IndocinFailed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability...G & W Laboratories, Inc. · D-0501-2017Class IITerminatedMar 8, 2017HealthA2Z CHEWABLE AspirincGMP deviations - presence of rubber particles found loose in the bulk product.Allegiant Health · D-0500-2017Class IITerminatedMar 8, 2017EYE WASHLack of assurance of sterilityUnited Exchange Corporation · D-0499-2017Class IITerminatedMar 8, 2017Eye WashLack of assurance of sterilityUnited Exchange Corporation · D-0498-2017Class IITerminatedMar 8, 2017Eye Irrigating SolutionLack of assurance of sterilityUnited Exchange Corporation · D-0497-2017Class ITerminatedMar 8, 2017EYE WASHNon-Sterility: Direct evidence of contamination for 2 lots based on FDA samples.United Exchange Corporation · D-0496-2017